Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation
Status:
NOT_YET_RECRUITING
Trial end date:
2028-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if PERTZYE works to treat steatorrhea in children and adults with Alagille Syndrome (ALGS) post liver transplant. It will also learn about the safety of PERTZYE. The main questions it aims to answer are:
* Does PERTZYE improve dietary fat absorption?
* Does PERTZYE improve stool frequency and consistency?
* Does PERTZYE improve abdominal signs and symptoms?
* What medical problems do participants have when taking PERTZYE? Researchers will compare the results when participants are taking and stop taking PERTZYE.
During the study, participants will:
* Consume a high fat diet
* Take PERTZYE every day with meals and snacks for up to 4 weeks
* Have scheduled checkups by phone or video by clinical staff
* Keep a diary of their symptoms and PERTZYE dosing
* Collect stool for laboratory testing